Namitecan
Product Specifications
UNSPSC Description
Namitecan is a potent topoisomerase I inhibitor, with antitumor property.
Target Antigen
Topoisomerase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/namitecan.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(/C=N/OCCN)C5=CC=CC=C5N=C4C3=C2)=O
Molecular Weight
434.44
References & Citations
[1]De Cesare M, et al. Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number. Clin Cancer Res. 2014 Feb 15;20(4):995-1006.|[2]Zuco V, et al. Efficacy of ST1968 (namitecan) on a topotecan-resistant squamous cell carcinoma. Biochem Pharmacol. 2010 Feb 15;79(4):535-41.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14821/Namitecan-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14821/Namitecan-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
372105-27-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TRC-D202370-2.5MG 2.5 mg
(11Beta)-11,17-Dihydroxy-21-(2-oxopropoxy)pregn-4-ene-3,20-dione
Ask
View Details 
OR1051161-01 100 mg
(S) -Benzyl 2- (aminomethyl) morpholine-4-carboxylate dihydrochloride
Ask
View Details 
OR1051161-02 250 mg
(S) -Benzyl 2- (aminomethyl) morpholine-4-carboxylate dihydrochloride
Ask
View Details 
